03.21.2017 - By Steve Ambrose
Prognos is a healthcare technology company using AI and advanced analytics. More than 7 Billion data points, 135 million patient files, and 500 proprietary algorithms put into play to drive early detection of chronic and ID-delayed diseases. Merck is onboard with investment…Cigna has rolled it out…and we have their CMO Dr. Jason Bhan with us today. In this episode, Dr. Steve and Dr. Bhan discuss: The power of Prognos' AI platform and risk-assessment engine Prognos vs. IBM's Watson A wide reach into life science, payer, and diagnostics industries Their bold new approach into early disease detection